Medior pockets $7M in first round

Medior of Malvern Hill, PA has rounded up $7 million in its first round of venture capital. Medior is developing therapeutics for the treatment of fibrotic disorders and diseases. Polaris Ventures and Morgenthaler Ventures led the round.

- see the release on Medior

Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.